Core Efficacy

Promotes Physiological GH Secretion: Mimics the function of endogenous GHRH, stimulating the pituitary gland to release GH in a pulsatile secretion pattern, conforming to the body's physiological rhythm.

Targeted Reduction of Visceral Fat: Primarily indicated for HIV-related lipodystrophy, it significantly reduces abdominal visceral fat accumulation and improves abnormal fat distribution (without affecting subcutaneous fat and muscle mass).

Supports Improved Metabolism and Quality of Life: Reducing visceral fat can help improve metabolic indicators such as blood lipids and insulin sensitivity, while alleviating appearance concerns caused by abnormal fat distribution, thus improving quality of life.